Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

ClinicalTrials.gov ID: NCT02633033

Public ClinicalTrials.gov record NCT02633033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 11:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Acthar Gel was first approved by the Food and Drug Administration in 1952. It has been used to treat many different illnesses, including multiple sclerosis. This study will observe how treatment with Acthar affected the daily lives of patients who suffer with relapsing/remitting MS. It will collect information on symptoms, recovery, treatment patterns and safety outcomes.

Study identification

NCT ID
NCT02633033
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Mallinckrodt
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 23, 2015
Primary completion
May 8, 2019
Completion
May 8, 2019
Last update posted
Dec 8, 2019

2015 – 2019

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
38
Facility City State ZIP Site status
Alabama Neurology Associates Homewood Alabama 35209
Territory Neurology & Research Institute Tucson Arizona 85704
Colorado Springs Neurological Associates Colorado Springs Colorado 80907
Advanced Neurosciences Research Fort Collins Colorado 80528
Associated Neurologists of Southern Connecticut Fairfield Connecticut 06824
MedStar Health Washington D.C. District of Columbia 20007
Emery Neuroscience Center Lighthouse PT Florida 33064
Neurology Associates Maitland Florida 32751
Cordova Research Institute Miami Florida 33155
Collier Neurologic Specialists Naples Florida 34102
Florida Neurological Center Ocala Florida 34471
Neurological Services of Orlando Orlando Florida 32806
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Negroski, Sutherland and Hanes Neurology Sarasota Florida 34239
Infinity Clinical Research Sunrise Florida 33351
Columbus Research & Wellness Institute Columbus Georgia 31904
Neurology of Central Georgia Macon Georgia 31210
Meridian Clinical Research Savannah Georgia 31406
College Park Family Care Center Overland Park Kansas 66212
University System of Maryland Baltimore Maryland 21201
International Neurorehabilitation Institute Lutherville Maryland 21093
Neurology Center of New England Foxborough Massachusetts 02035
Milford Regional Medical Center Hopedale Massachusetts 01747
Detroit Clinical Research Center Farmington Hills Michigan 48334
CentraState Medical Center Freehold New Jersey 07728
Strotira, Inc. New York New York 11714
Alpha Neurology Staten Island New York 10306
Five Towns Neurology Woodmere New York 11598
Braunstein Neurology Mooresville North Carolina 28117
The Toledo Clinic Toledo Ohio 43623
Oak Clinic for Multiple Sclerosis Uniontown Ohio 44685
Optimum Neurology Bala-Cynwyd Pennsylvania 19004
Irene Greenhouse MD Jamison Pennsylvania 18929
Neurology and Stroke Associates Lititz Pennsylvania 17543
D. Gary Kolva, MD, Neurology West Reading Pennsylvania 19610
Colonial Healthcare Sumter South Carolina 29150
Ogden Clinic Ogden Utah 84403
Dominion Neurological Services Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02633033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2019 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02633033 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →